Leproust Emily M.
Leproust Emily M., CEO, reported an open-market or private sale at Twist Bioscience Corp involving 2302.000000 shares for an estimated $282280.45. Reported holdings after the transaction were 768427.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 08, 2026
- Filing date
- Sep 10, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 770,729 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
TWST price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001214659-26-011556 Common Stock
- Transaction date
- Sep 08, 2026 Filed Sep 10, 2026, 08:00 PM · 2d delay
- Shares
- 2,302 sh $122.62 per share
- Estimated value
- -$282k Computed from shares × price
- Holdings after
- 768,427 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Executive Officer
- F1
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by t…
- F2
The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter,…
- F3
The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the sha…
- F4
20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereaf…
- F5
25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's contin…
- F6
Represents performance stock options granted to the reporting person on September 1, 2020, that vested and became exercisable on December 19, 2022 as a result of the reporting person having met the ap…
0 other transactions
0 recent txs